Selected research
Industry Growth & Trends
Global Oxytocin Industry Growth and Trends Forecast to 2032
Market perspective
The global Oxytocin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Oxytocin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Oxytocin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oxytocin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Oxytocin include Tianjin Biochem Pharmaceutical, Shanghai Harvest Pharmaceutical, Novartis, Nanjing Xinbai Pharmaceutical, Mylan, Pfizer, GSK, Chengdu Hepatunn and Anhui Hongye Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Oxytocin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oxytocin market size, estimates, and forecasts are presented in terms of sales volume (k tons) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oxytocin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oxytocin.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Oxytocin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oxytocin Market by Company
Tianjin Biochem Pharmaceutical
Shanghai Harvest Pharmaceutical
Novartis
Nanjing Xinbai Pharmaceutical
Mylan
Pfizer
GSK
Chengdu Hepatunn
Anhui Hongye Pharmaceutical
Suzhou Tianji Bio-Pharmaceutical
SPH NO.1 Biochemical & Pharmaceutical
Shanghai Ceneral Pharmaceutical
Ningbo Renjian Pharmaceutical Group
Hybio Pharmaceutical
Grindeks
Oxytocin Segment by Type
Injection
Nasal Spray
Oxytocin Segment by Application
For Baby Born
For Comestic
Others
Oxytocin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxytocin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxytocin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxytocin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oxytocin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Oxytocin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Injection
- Nasal Spray
Applications
- For Baby Born
- For Comestic
- Others
Companies covered
- Tianjin Biochem Pharmaceutical
- Shanghai Harvest Pharmaceutical
- Novartis
- Nanjing Xinbai Pharmaceutical
- Mylan
- Pfizer
- GSK
- Chengdu Hepatunn
- Anhui Hongye Pharmaceutical
- Suzhou Tianji Bio-Pharmaceutical
- SPH NO.1 Biochemical & Pharmaceutical
- Shanghai Ceneral Pharmaceutical
- Ningbo Renjian Pharmaceutical Group
- Hybio Pharmaceutical
- Grindeks
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Oxytocin Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Oxytocin Sales Estimates and Forecasts (2021-2032)
- 1.3 Oxytocin Market by Type
- 1.3.1 Injection
- 1.3.2 Nasal Spray
- 1.4 Global Oxytocin Market Size by Type
- 1.4.1 Global Oxytocin Market Size Overview by Type (2021-2032)
- 1.4.2 Global Oxytocin Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Oxytocin Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Oxytocin Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Oxytocin Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Oxytocin Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Oxytocin Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Oxytocin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Oxytocin Industry Trends
- 2.2 Oxytocin Industry Drivers
- 2.3 Oxytocin Industry Opportunities and Challenges
- 2.4 Oxytocin Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Oxytocin Revenue (2021-2026)
- 3.2 Global Top Players by Oxytocin Sales (2021-2026)
- 3.3 Global Top Players by Oxytocin Price (2021-2026)
- 3.4 Global Oxytocin Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Oxytocin Major Company Production Sites & Headquarters
- 3.6 Global Oxytocin Company, Product Type & Application
- 3.7 Global Oxytocin Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Oxytocin Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Oxytocin Players Market Share by Revenue in 2025
- 3.8.3 2025 Oxytocin Tier 1, Tier 2, and Tier 3
4 Oxytocin Regional Status and Outlook
- 4.1 Global Oxytocin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Oxytocin Historic Market Size by Region
- 4.2.1 Global Oxytocin Sales in Volume by Region (2021-2026)
- 4.2.2 Global Oxytocin Sales in Value by Region (2021-2026)
- 4.2.3 Global Oxytocin Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Oxytocin Forecasted Market Size by Region
- 4.3.1 Global Oxytocin Sales in Volume by Region (2027-2032)
- 4.3.2 Global Oxytocin Sales in Value by Region (2027-2032)
- 4.3.3 Global Oxytocin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oxytocin by Application
- 5.1 Oxytocin Market by Application
- 5.1.1 For Baby Born
- 5.1.2 For Comestic
- 5.1.3 Others
- 5.2 Global Oxytocin Market Size by Application
- 5.2.1 Global Oxytocin Market Size Overview by Application (2021-2032)
- 5.2.2 Global Oxytocin Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Oxytocin Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Oxytocin Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Oxytocin Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Oxytocin Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Oxytocin Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Oxytocin Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Tianjin Biochem Pharmaceutical
- 6.1.1 Tianjin Biochem Pharmaceutical Company Information
- 6.1.2 Tianjin Biochem Pharmaceutical Business Overview
- 6.1.3 Tianjin Biochem Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Tianjin Biochem Pharmaceutical Oxytocin Product Portfolio
- 6.1.5 Tianjin Biochem Pharmaceutical Recent Developments
- 6.2 Shanghai Harvest Pharmaceutical
- 6.2.1 Shanghai Harvest Pharmaceutical Company Information
- 6.2.2 Shanghai Harvest Pharmaceutical Business Overview
- 6.2.3 Shanghai Harvest Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Shanghai Harvest Pharmaceutical Oxytocin Product Portfolio
- 6.2.5 Shanghai Harvest Pharmaceutical Recent Developments
- 6.3 Novartis
- 6.3.1 Novartis Company Information
- 6.3.2 Novartis Business Overview
- 6.3.3 Novartis Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Novartis Oxytocin Product Portfolio
- 6.3.5 Novartis Recent Developments
- 6.4 Nanjing Xinbai Pharmaceutical
- 6.4.1 Nanjing Xinbai Pharmaceutical Company Information
- 6.4.2 Nanjing Xinbai Pharmaceutical Business Overview
- 6.4.3 Nanjing Xinbai Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Nanjing Xinbai Pharmaceutical Oxytocin Product Portfolio
- 6.4.5 Nanjing Xinbai Pharmaceutical Recent Developments
- 6.5 Mylan
- 6.5.1 Mylan Company Information
- 6.5.2 Mylan Business Overview
- 6.5.3 Mylan Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Mylan Oxytocin Product Portfolio
- 6.5.5 Mylan Recent Developments
- 6.6 Pfizer
- 6.6.1 Pfizer Company Information
- 6.6.2 Pfizer Business Overview
- 6.6.3 Pfizer Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Pfizer Oxytocin Product Portfolio
- 6.6.5 Pfizer Recent Developments
- 6.7 GSK
- 6.7.1 GSK Company Information
- 6.7.2 GSK Business Overview
- 6.7.3 GSK Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 GSK Oxytocin Product Portfolio
- 6.7.5 GSK Recent Developments
- 6.8 Chengdu Hepatunn
- 6.8.1 Chengdu Hepatunn Company Information
- 6.8.2 Chengdu Hepatunn Business Overview
- 6.8.3 Chengdu Hepatunn Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Chengdu Hepatunn Oxytocin Product Portfolio
- 6.8.5 Chengdu Hepatunn Recent Developments
- 6.9 Anhui Hongye Pharmaceutical
- 6.9.1 Anhui Hongye Pharmaceutical Company Information
- 6.9.2 Anhui Hongye Pharmaceutical Business Overview
- 6.9.3 Anhui Hongye Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Anhui Hongye Pharmaceutical Oxytocin Product Portfolio
- 6.9.5 Anhui Hongye Pharmaceutical Recent Developments
- 6.10 Suzhou Tianji Bio-Pharmaceutical
- 6.10.1 Suzhou Tianji Bio-Pharmaceutical Company Information
- 6.10.2 Suzhou Tianji Bio-Pharmaceutical Business Overview
- 6.10.3 Suzhou Tianji Bio-Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Suzhou Tianji Bio-Pharmaceutical Oxytocin Product Portfolio
- 6.10.5 Suzhou Tianji Bio-Pharmaceutical Recent Developments
- 6.11 SPH NO.1 Biochemical & Pharmaceutical
- 6.11.1 SPH NO.1 Biochemical & Pharmaceutical Company Information
- 6.11.2 SPH NO.1 Biochemical & Pharmaceutical Business Overview
- 6.11.3 SPH NO.1 Biochemical & Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 SPH NO.1 Biochemical & Pharmaceutical Oxytocin Product Portfolio
- 6.11.5 SPH NO.1 Biochemical & Pharmaceutical Recent Developments
- 6.12 Shanghai Ceneral Pharmaceutical
- 6.12.1 Shanghai Ceneral Pharmaceutical Company Information
- 6.12.2 Shanghai Ceneral Pharmaceutical Business Overview
- 6.12.3 Shanghai Ceneral Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Shanghai Ceneral Pharmaceutical Oxytocin Product Portfolio
- 6.12.5 Shanghai Ceneral Pharmaceutical Recent Developments
- 6.13 Ningbo Renjian Pharmaceutical Group
- 6.13.1 Ningbo Renjian Pharmaceutical Group Company Information
- 6.13.2 Ningbo Renjian Pharmaceutical Group Business Overview
- 6.13.3 Ningbo Renjian Pharmaceutical Group Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Ningbo Renjian Pharmaceutical Group Oxytocin Product Portfolio
- 6.13.5 Ningbo Renjian Pharmaceutical Group Recent Developments
- 6.14 Hybio Pharmaceutical
- 6.14.1 Hybio Pharmaceutical Company Information
- 6.14.2 Hybio Pharmaceutical Business Overview
- 6.14.3 Hybio Pharmaceutical Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Hybio Pharmaceutical Oxytocin Product Portfolio
- 6.14.5 Hybio Pharmaceutical Recent Developments
- 6.15 Grindeks
- 6.15.1 Grindeks Company Information
- 6.15.2 Grindeks Business Overview
- 6.15.3 Grindeks Oxytocin Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Grindeks Oxytocin Product Portfolio
- 6.15.5 Grindeks Recent Developments
7 North America by Country
- 7.1 North America Oxytocin Sales by Country
- 7.1.1 North America Oxytocin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Oxytocin Sales by Country (2021-2026)
- 7.1.3 North America Oxytocin Sales Forecast by Country (2027-2032)
- 7.2 North America Oxytocin Market Size by Country
- 7.2.1 North America Oxytocin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Oxytocin Market Size by Country (2021-2026)
- 7.2.3 North America Oxytocin Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Oxytocin Sales by Country
- 8.1.1 Europe Oxytocin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Oxytocin Sales by Country (2021-2026)
- 8.1.3 Europe Oxytocin Sales Forecast by Country (2027-2032)
- 8.2 Europe Oxytocin Market Size by Country
- 8.2.1 Europe Oxytocin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Oxytocin Market Size by Country (2021-2026)
- 8.2.3 Europe Oxytocin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Oxytocin Sales by Country
- 9.1.1 Asia-Pacific Oxytocin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Oxytocin Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Oxytocin Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Oxytocin Market Size by Country
- 9.2.1 Asia-Pacific Oxytocin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Oxytocin Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Oxytocin Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Oxytocin Sales by Country
- 10.1.1 South America Oxytocin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Oxytocin Sales by Country (2021-2026)
- 10.1.3 South America Oxytocin Sales Forecast by Country (2027-2032)
- 10.2 South America Oxytocin Market Size by Country
- 10.2.1 South America Oxytocin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Oxytocin Market Size by Country (2021-2026)
- 10.2.3 South America Oxytocin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Oxytocin Sales by Country
- 11.1.1 Middle East and Africa Oxytocin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Oxytocin Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Oxytocin Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Oxytocin Market Size by Country
- 11.2.1 Middle East and Africa Oxytocin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Oxytocin Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Oxytocin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Oxytocin Value Chain Analysis
- 12.1.1 Oxytocin Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Oxytocin Production Mode & Process
- 12.2 Oxytocin Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Oxytocin Distributors
- 12.2.3 Oxytocin Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst